2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide

Identification

Generic Name
2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide
DrugBank Accession Number
DB07826
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 365.81
Monoisotopic: 365.08187109
Chemical Formula
C21H16ClNO3
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UGag-Pol polyproteinNot Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as benzophenones. These are organic compounds containing a ketone attached to two phenyl groups.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzophenones
Direct Parent
Benzophenones
Alternative Parents
Diphenylmethanes / Aryl-phenylketones / Anilides / Phenoxy compounds / Phenol ethers / N-arylamides / Benzoyl derivatives / Chlorobenzenes / Alkyl aryl ethers / Aryl chlorides
show 5 more
Substituents
Alkyl aryl ether / Anilide / Aromatic homomonocyclic compound / Aryl chloride / Aryl halide / Aryl ketone / Aryl-phenylketone / Benzophenone / Benzoyl / Carbonyl group
show 20 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
DTGVSZSMDOMAEB-UHFFFAOYSA-N
InChI
InChI=1S/C21H16ClNO3/c22-16-11-12-19(18(13-16)21(25)15-7-3-1-4-8-15)26-14-20(24)23-17-9-5-2-6-10-17/h1-13H,14H2,(H,23,24)
IUPAC Name
2-(2-benzoyl-4-chlorophenoxy)-N-phenylacetamide
SMILES
ClC1=CC=C(OCC(=O)NC2=CC=CC=C2)C(=C1)C(=O)C1=CC=CC=C1

References

General References
Not Available
PubChem Compound
465669
PubChem Substance
99444297
ChemSpider
409335
ChEMBL
CHEMBL296939
PDBe Ligand
GFA
PDB Entries
3dle

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.000475 mg/mLALOGPS
logP4.41ALOGPS
logP4.79Chemaxon
logS-5.9ALOGPS
pKa (Strongest Acidic)12.58Chemaxon
pKa (Strongest Basic)-4.9Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area55.4 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity102.26 m3·mol-1Chemaxon
Polarizability36.77 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9956
Blood Brain Barrier+0.9775
Caco-2 permeable+0.6028
P-glycoprotein substrateNon-substrate0.746
P-glycoprotein inhibitor INon-inhibitor0.5103
P-glycoprotein inhibitor IINon-inhibitor0.6776
Renal organic cation transporterNon-inhibitor0.8423
CYP450 2C9 substrateNon-substrate0.7879
CYP450 2D6 substrateNon-substrate0.7994
CYP450 3A4 substrateSubstrate0.5746
CYP450 1A2 substrateInhibitor0.9319
CYP450 2C9 inhibitorInhibitor0.8925
CYP450 2D6 inhibitorNon-inhibitor0.9389
CYP450 2C19 inhibitorInhibitor0.9634
CYP450 3A4 inhibitorNon-inhibitor0.8121
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.9207
Ames testNon AMES toxic0.679
CarcinogenicityNon-carcinogens0.7705
BiodegradationNot ready biodegradable0.9618
Rat acute toxicity2.0709 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9707
hERG inhibition (predictor II)Non-inhibitor0.839
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0a4l-5921000000-3c4e56313f257e249226
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0349000000-0c9e25512d6824c9664b
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0005-9076000000-56a9a92742018a55959a
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-06e9-0923000000-ea7da758eb77fc657bfa
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-02ac-8229000000-3e476f1ea192d4b2148a
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0ar0-4901000000-bbe6bbb10239862a6602
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00pl-9221000000-ff93fbe7689ffa382057
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-178.80621
predicted
DeepCCS 1.0 (2019)
[M+H]+181.16422
predicted
DeepCCS 1.0 (2019)
[M+Na]+188.09872
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Not Available
Pharmacological action
Unknown
General Function
Zinc ion binding
Specific Function
Gag-Pol polyprotein: Mediates, with Gag polyrotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spher...
Gene Name
gag-pol
Uniprot ID
P04585
Uniprot Name
Gag-Pol polyprotein
Molecular Weight
162041.05 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 15, 2010 21:26 / Updated at June 12, 2020 16:52